Clinical Trial Update: Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effect of EGb761 (Ginkgo biloba extract) on brain glucose metabolism in elderly participants categorized by cognitive function; resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• EGb761 (Ginkgo biloba extract)

Snippet

Sponsor: Ipsen | Conditions: Alzheimer's Disease, Cognitive Impairment | Phase 2 | Status: COMPLETED | Results posted: 2016-03-28